First Time Loading...

Inari Medical Inc
NASDAQ:NARI

Watchlist Manager
Inari Medical Inc Logo
Inari Medical Inc
NASDAQ:NARI
Watchlist
Price: 38.64 USD -0.16% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

Inari Medical, Inc. operates as a medical device company. [ Read More ]

The intrinsic value of one NARI stock under the Base Case scenario is 26.44 USD. Compared to the current market price of 38.64 USD, Inari Medical Inc is Overvalued by 32%.

Key Points:
NARI Intrinsic Value
Base Case
26.44 USD
Overvaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Inari Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NARI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Inari Medical Inc

Provide an overview of the primary business activities
of Inari Medical Inc.

What unique competitive advantages
does Inari Medical Inc hold over its rivals?

What risks and challenges
does Inari Medical Inc face in the near future?

Has there been any significant insider trading activity
in Inari Medical Inc recently?

Summarize the latest earnings call
of Inari Medical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inari Medical Inc.

Provide P/S
for Inari Medical Inc.

Provide P/E
for Inari Medical Inc.

Provide P/OCF
for Inari Medical Inc.

Provide P/FCFE
for Inari Medical Inc.

Provide P/B
for Inari Medical Inc.

Provide EV/S
for Inari Medical Inc.

Provide EV/GP
for Inari Medical Inc.

Provide EV/EBITDA
for Inari Medical Inc.

Provide EV/EBIT
for Inari Medical Inc.

Provide EV/OCF
for Inari Medical Inc.

Provide EV/FCFF
for Inari Medical Inc.

Provide EV/IC
for Inari Medical Inc.

Show me price targets
for Inari Medical Inc made by professional analysts.

What are the Revenue projections
for Inari Medical Inc?

How accurate were the past Revenue estimates
for Inari Medical Inc?

What are the Net Income projections
for Inari Medical Inc?

How accurate were the past Net Income estimates
for Inari Medical Inc?

What are the EPS projections
for Inari Medical Inc?

How accurate were the past EPS estimates
for Inari Medical Inc?

What are the EBIT projections
for Inari Medical Inc?

How accurate were the past EBIT estimates
for Inari Medical Inc?

Compare the revenue forecasts
for Inari Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inari Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inari Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inari Medical Inc compared to its peers.

Compare the P/E ratios
of Inari Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Inari Medical Inc with its peers.

Analyze the financial leverage
of Inari Medical Inc compared to its main competitors.

Show all profitability ratios
for Inari Medical Inc.

Provide ROE
for Inari Medical Inc.

Provide ROA
for Inari Medical Inc.

Provide ROIC
for Inari Medical Inc.

Provide ROCE
for Inari Medical Inc.

Provide Gross Margin
for Inari Medical Inc.

Provide Operating Margin
for Inari Medical Inc.

Provide Net Margin
for Inari Medical Inc.

Provide FCF Margin
for Inari Medical Inc.

Show all solvency ratios
for Inari Medical Inc.

Provide D/E Ratio
for Inari Medical Inc.

Provide D/A Ratio
for Inari Medical Inc.

Provide Interest Coverage Ratio
for Inari Medical Inc.

Provide Altman Z-Score Ratio
for Inari Medical Inc.

Provide Quick Ratio
for Inari Medical Inc.

Provide Current Ratio
for Inari Medical Inc.

Provide Cash Ratio
for Inari Medical Inc.

What is the historical Revenue growth
over the last 5 years for Inari Medical Inc?

What is the historical Net Income growth
over the last 5 years for Inari Medical Inc?

What is the current Free Cash Flow
of Inari Medical Inc?

Financials

Balance Sheet Decomposition
Inari Medical Inc

Current Assets 235.6m
Cash & Short-Term Investments 115.5m
Receivables 70.1m
Other Current Assets 50m
Non-Current Assets 438.7m
Long-Term Investments 1.5m
PP&E 69.3m
Intangibles 365.2m
Other Non-Current Assets 2.6m
Current Liabilities 76.3m
Accounts Payable 10.6m
Accrued Liabilities 65.8m
Non-Current Liabilities 133m
Other Non-Current Liabilities 133m
Efficiency

Earnings Waterfall
Inari Medical Inc

Revenue
493.6m USD
Cost of Revenue
-59.1m USD
Gross Profit
434.6m USD
Operating Expenses
-438.2m USD
Operating Income
-3.6m USD
Other Expenses
2m USD
Net Income
-1.6m USD

Free Cash Flow Analysis
Inari Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

NARI Profitability Score
Profitability Due Diligence

Inari Medical Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
50/100
Profitability
Score

Inari Medical Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

NARI Solvency Score
Solvency Due Diligence

Inari Medical Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
65/100
Solvency
Score

Inari Medical Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NARI Price Targets Summary
Inari Medical Inc

Wall Street analysts forecast NARI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NARI is 74.65 USD with a low forecast of 47.47 USD and a high forecast of 105 USD.

Lowest
Price Target
47.47 USD
23% Upside
Average
Price Target
74.65 USD
93% Upside
Highest
Price Target
105 USD
172% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NARI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NARI Price
Inari Medical Inc

1M 1M
-15%
6M 6M
-31%
1Y 1Y
-41%
3Y 3Y
-63%
5Y 5Y
-9%
10Y 10Y
-9%
Annual Price Range
38.64
52w Low
38.64
52w High
71.67
Price Metrics
Average Annual Return 25.69%
Standard Deviation of Annual Returns 69.39%
Max Drawdown -69%
Shares Statistics
Market Capitalization 2.2B USD
Shares Outstanding 57 960 600
Percentage of Shares Shorted 8.73%

NARI Return Decomposition
Main factors of price return

What is price return decomposition?

NARI News

Other Videos

Company Profile

Inari Medical Inc Logo
Inari Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

2.2B USD

Dividend Yield

0%

Description

Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 800 full-time employees. The company went IPO on 2020-05-22. The firm operates through the development and commercialization of invasive mechanical thrombectomy devices to treat thromboembolism in the venous system. Its product offerings consist of two minimally invasive, catheter-based mechanical thrombectomy systems, which are for venous system and the treatment of the two distinct manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The Company’s products include ClotTriever System, FlowTriever System, FlowSaver, FlowStasis and FlowTriever 2. The ClotTriever system is a mechanical thrombectomy system designed to core, capture and remove large clots from large vessels and is used to treat DVT and its components include ClotTriever Catheter and ClotTriever Sheath. The FlowTriever is a large bore catheter-based aspiration and mechanical thrombectomy system designed to remove large clots from large vessels to treat PE.

Contact

CALIFORNIA
Irvine
6001 Oak Canyon, Suite 100, Suite 100
+19499234747.0
https://www.inarimedical.com

IPO

2020-05-22

Employees

800

Officers

CEO, President & Director
Mr. Andrew J. Hykes
Chief Financial Officer
Mr. Mitchell C. Hill
Chief Medical Officer
Dr. Thomas M. Tu M.D.
Senior Vice President of Operations
Mr. Paul A. Koehn
Senior Vice President of Finance, Accounting, Strategy & Business Development
Mr. Kevin Strange
Vice President of Investor Relations
Mr. John Hsu C.F.A.
Show More
General Counsel & Secretary
Ms. Angela Ahmad
Senior Vice President of Marketing
Mr. Eric Khairy
Senior Vice President of Sales
Mr. John R. Borrell
Senior VP & GM of LimFlow
Ms. Tara Dunn
Show Less

See Also

Discover More
What is the Intrinsic Value of one NARI stock?

The intrinsic value of one NARI stock under the Base Case scenario is 26.44 USD.

Is NARI stock undervalued or overvalued?

Compared to the current market price of 38.64 USD, Inari Medical Inc is Overvalued by 32%.